Study heart events in people with breast cancer
Part of Cancer, Heart & circulation, Injuries & trauma, Skin clinical trials.
This study looks at what heart-related side effects happen in women with breast cancer who are planned to receive chemotherapy. It may help doctors better understand and monitor these risks during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You can read and understand English
- You have breast cancer that is planned for chemotherapy (stage I to III)
- Your treatment plan is aimed at cure (not just comfort care or other goals)
- You can follow the study steps and work with the study team
- You can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This study looks at how breast cancer medicines affect the heart. It may help doctors better prevent, spot early, and manage heart side effects from trastuzumab and/or anthracycline chemotherapy.
This study tests a method to predict and warn about heart damage from a common type of breast cancer chemotherapy. If you have HER2-positive breast cancer and will receive anthracycline drugs, this trial may help monitor your heart health.
This trial tests whether grape polyphenols can help protect the heart in women being treated for breast cancer with certain chemotherapy drugs that can harm the heart. If you are at high risk for heart problems from chemo, this study may offer a way to reduce that risk.
This study tests whether a supervised exercise program can help protect the heart from damage caused by certain chemotherapy drugs (EC and docetaxel) used to treat early-stage breast cancer.
This study looks at whether a simple blood test can spot early signs of heart damage from certain breast cancer treatments (anthracycline chemo or anti-HER2 drugs). The goal is to protect your heart while you get the cancer treatment you need.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.